Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

Abstract Background 5-Fluorouracil (5FU), Folinic acid (FA), and Oxaliplatin (FOLFOX) or 5FU, FA, and Irinotecan (FOLFIRI) are standard regimens for palliative chemotherapy of metastatic colon cancer. Since data showing the influence of dose reduction in palliative treatment are rare, the objective...

Full description

Bibliographic Details
Main Authors: Stefan Munker, Michael Gerken, Petra Fest, Claudia Ott, Elisabeth Schnoy, Stefan Fichtner-Feigl, Philipp Wiggermann, Martin Vogelhuber, Wolfgang Herr, Christian Stroszczynski, Hans Jürgen Schlitt, Matthias Evert, Michael Reng, Monika Klinkhammer-Schalke, Andreas Teufel
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Cancer
Subjects:
Dose reduction
Cancer
Colorectal cancer
Chemotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-018-4380-z

Internet

http://link.springer.com/article/10.1186/s12885-018-4380-z

Similar Items